A. Schlegelmilch

Generation of “LYmph Node Derived Antibody Libraries” (LYNDAL) for selecting fully human antibody fragments with therapeutic potential

D. Jäger, R. Kontermann, G. Dyckhoff, 2013, mAbs.

High treatment efficacy by dual targeting of Burkitt’s lymphoma xenografted mice with a 177Lu-based CD22-specific radioimmunoconjugate and rituximab

Michaela A. E. Arndt, D. Jäger, U. Haberkorn, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

An EGF receptor targeting Ranpirnase-diabody fusion protein mediates potent antitumour activity in vitro and in vivo.

Michaela A. E. Arndt, C. Körber, N. Halama, 2015, Cancer letters.